Precigen, Inc., originally known as Intrexon Corporation, is a biopharmaceutical company based in Germantown, Maryland, focusing on developing gene and cell therapies. With a foundation laid in 1998, Precigen advances treatments for a variety of diseases, including those in immuno-oncology, autoimmune disorders, and infectious diseases. The company's innovative precision technology propels its pipeline of preclinical and clinical therapies towards commercialization, aiming to revolutionize biotherapeutic solutions.
Are you interested in investing in penny stocks? Though doing so does come with risk, making the right investment decisions in the penny stock category can produce eye-opening returns. While the profits…
A beneficial owner made a huge buy of shares in a trucking company this past week. That was not the only big insider buying though.
